Abstract: Disclosed are crystal form A and crystal form B of a compound represented by formula (I), and application thereof in the preparation of medicaments for treating HBV-related diseases.
Type:
Grant
Filed:
August 23, 2019
Date of Patent:
April 9, 2024
Assignee:
Fujian Akeylink Biotechnology Co., Ltd.
Inventors:
Jing Wang, Zhigan Jiang, Haiying He, Yaxun Yang